Categories: NewsPharmaceutical

Shook Expands Regional Litigation Capabilities with Addition of Holly Polglase in Boston

BOSTON, Sept. 4, 2025 /PRNewswire/ — Holly Polglase, a seasoned litigator with extensive experience in the defense and trial of complex product liability, toxic tort, general liability and commercial matters, has joined Shook, Hardy & Bacon as a partner in the Boston office.

Polglase has represented major national and multinational companies across the supply chain, including product manufacturers and the companies that service them, in the automotive, pharmaceutical and medical device industries, among many others.

“We’ve worked with Holly extensively over the years, making her addition not just an important strategic expansion of our capabilities in Boston and the Northeast, but a natural fit,” said Paul Williams, co-chair of Shook’s General Liability Litigation Practice.

“Holly’s technical knowledge and trial experience, her ability to creatively solve problems and our longstanding relationship make her a compelling addition to the firm,” said Shook Chair Madeleine McDonough.

“This is a great opportunity to join a firm I’ve long admired and to work with lawyers I’ve counted as friends throughout my career,” said Polglase.

Also joining with Polglase is Senior Counsel Matthew Bown, who has extensive experience in product liability and commercial litigation matters for large and small companies in a range of industries.

About Shook, Hardy & Bacon

Founded in 1889, Shook, Hardy & Bacon L.L.P. has 18 offices in the United States with attorneys and professional staff serving clients in the health, science and technology sectors in areas ranging from product liability defense and business litigation to intellectual property prosecution and litigation, environmental and toxic tort, privacy and data security and regulatory counseling.

View original content to download multimedia:https://www.prnewswire.com/news-releases/shook-expands-regional-litigation-capabilities-with-addition-of-holly-polglase-in-boston-302546858.html

SOURCE Shook, Hardy & Bacon L.L.P.

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

1 hour ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

1 hour ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

1 hour ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

1 hour ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

1 hour ago